You are searching for: hsa04610

---

T74363 Target Info	Target Name	Urokinase plasminogen activator surface receptor (PLAUR)
	Target type	Successful Target
	Disease	High-risk myelofibrosis; Essential thrombocythemia;
	Drugs	Ruxolitinib	Drug Info

T60708 Target Info	Target Name	Complement C5 (CO5)
	Target type	Successful Target
	Disease	Large B Cell Lymphoma; Geographic atrophy;
	Drugs	Pozelimab	Drug Info

T98022 Target Info	Target Name	Carboxypeptidase B2 (CPB2)
	Target type	Clinical trial Target
	Disease	Cerebrovascular ischaemia; Ischemic stroke;
	Drugs	SAR-126119	Drug Info

T15556 Target Info	Target Name	Endothelial plasminogen activator inhibitor (SERPINE1)
	Target type	Clinical trial Target
	Disease	Asthma; Thrombosis;
	Drugs	THR-18	Drug Info

T58589 Target Info	Target Name	B1 bradykinin receptor (BDKRB1)
	Target type	Clinical trial Target
	Disease	Diabetic macular edema; Rheumatoid arthritis;
	Drugs	SSR-240612	Drug Info

T15439 Target Info	Target Name	C5a anaphylatoxin chemotactic receptor (C5AR1)
	Target type	Successful Target
	Disease	Anca-associated vasculitis; Atopic dermatitis;
	Drugs	Avacopan	Drug Info

T26851 Target Info	Target Name	Complement C3 (CO3)
	Target type	Successful Target
	Disease	Non-hodgkin lymphoma; Breast cancer;
	Drugs	Pegcetacoplan	Drug Info

T66383 Target Info	Target Name	Complement factor D (CFD)
	Target type	Clinical trial Target
	Disease	Paroxysmal nocturnal haemoglobinuria; Geographic retinal atrophy;
	Drugs	Lampalizumab	Drug Info

T23348 Target Info	Target Name	von Willebrand factor (VWF)
	Target type	Successful Target
	Disease	Thrombotic thrombocytopenic purpura; Von willebrand disease;
	Drugs	Vonvendi	Drug Info

T46040 Target Info	Target Name	Coagulation factor XI (F11)
	Target type	Clinical trial Target
	Disease	Ischemic stroke; Atrial fibrillation;
	Drugs	A186	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.